Have a personal or library account? Click to login
Impact of cardiac magnetic resonance on the diagnosis and management of patients with cardiomyopathies Cover

Impact of cardiac magnetic resonance on the diagnosis and management of patients with cardiomyopathies

Romanian Journal of Cardiology
Volume 34 (2024): Issue 4 (December 2024)
By: Oana-Andreea Popa,  Sebastian Onciul,  Thedor Badea,  Denisa Marian,  Bogdan Rac-Albu,  Mihaela Amzulescu,  Claudia Bugeac,  Oana Chiriac,  Luminița Tomescu,  Valeriu Gheorghita and  Andrei Roșu  
Open Access
|Sep 2024

References

  1. Masarone D, Kaski JP, Pacileo G, et al. Epidemiology and clinical aspects of genetic cardiomyopathies. Heart Fail Clin. 2018 Apr;14(2):119–128. doi: 10.1016/j.hfc.2017.12.007.
    Open DOISearch in Google ScholarBack to article
  2. Soriano CJ, Ridocci F, Estornell J, et al. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. J Am Coll Cardiol. 2005;45(5):743–748. doi: 10.1016/j.jacc.2004.11.037.
    Open DOISearch in Google ScholarBack to article
  3. Lin LQ, Kazmirczak FE, Chen KH, et al. Impact of cardiovascular magnetic resonance imaging on identifying the etiology of cardiomyopathy in patients undergoing cardiac transplantation. Sci Rep. 2018;8:34648. doi: 10.1038/s41598-018-34648-5.
    Open DOISearch in Google ScholarBack to article
  4. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and longterm survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342(15):1077–1084. doi: 10.1056/NEJM200004133421502.
    Open DOISearch in Google ScholarBack to article
  5. Bozkurt B, Colvin M, Cook J, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: A scientific statement from the American Heart Association. Circulation. 2016;134(8). doi: 10.1161/CIR.0000000000000455.
    Open DOISearch in Google ScholarBack to article
  6. Kwong RY, Petersen SE, Schulz-Menger J, et al. The global cardiovascular magnetic resonance registry (GCMR) of the society for cardiovascular magnetic resonance (SCMR): Its goals, rationale, data infrastructure, and current developments. J Cardiovasc Magn Reson. 2017;19(1):23. doi: 10.1186/s12968-016-0321-7.
    Open DOISearch in Google ScholarBack to article
  7. Vermes E, Carbone I, Friedrich MG, et al. Patterns of myocardial late enhancement: Typical and atypical features. Arch Cardiovasc Dis. 2012;105(5):300–308. doi: 10.1016/j.acvd.2011.12.006.
    Open DOISearch in Google ScholarBack to article
  8. Doltra A, Amundsen BH, Gebker R, et al. Emerging concepts for myocardial late gadolinium enhancement MRI. Curr Cardiol Rev. 2013;9(3):185–190. doi: 10.2174/1573403X113099990030.
    Open DOISearch in Google ScholarBack to article
  9. Satoh H, Sano M, Suwa K, et al. Distribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in the differential diagnosis, clinical features, and prognosis. World J Cardiol. 2014;6(7):585–601. doi: 10.4330/wjc.v6.i7.585.
    Open DOISearch in Google ScholarBack to article
  10. Franco A, Javidi S, Ruehm SG. Delayed myocardial enhancement in cardiac magnetic resonance imaging. J Radiol Case Rep. 2015;9(6):6–18. doi: 10.3941/jrcr.v9i6.2328.
    Open DOISearch in Google ScholarBack to article
  11. Von Knobelsdorff-Brenkenhoff F, Schulz-Menger J. Cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology: A comprehensive summary and update. J Cardiovasc Magn Reson. 2023;25(1):42. doi: 10.1186/s12968-023-00950-z.
    Open DOISearch in Google ScholarBack to article
  12. Arbelo E, Protonotarios A, Gimeno JR, et al. Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC). Eur Heart J. 2023;44(37):3503–3626. doi: 10.1093/eurheartj/ehad194.
    Open DOISearch in Google ScholarBack to article
  13. Puntmann VO, Valbuena S, Hinojar R, et al. Society for Cardiovascular Magnetic Resonance (SCMR) expert consensus for CMR imaging end points in clinical research: Part I-analytical validation and clinical qualification. J Cardiovasc Magn Reson. 2018;20(1):67. doi: 10.1186/s12968-018-0484-5.
    Open DOISearch in Google ScholarBack to article
  14. Patel AR, Kramer CM. Role of cardiac magnetic resonance in the diagnosis and prognosis of nonischemic cardiomyopathy. JACC Cardiovasc Imaging. 2017;10(10 Pt A):1180–1193. doi: 10.1016/j.jcmg.2017.08.005.
    Open DOISearch in Google ScholarBack to article
  15. Kramer CM, Chandrashekhar Y. Multiparametric CMR in cardiomyopathies: Beyond diagnosis and toward prognosis. JACC Cardiovasc Imaging. 2019;12(8):1712–1714. doi: 10.1016/j.jcmg.2019.06.019.
    Open DOISearch in Google ScholarBack to article
  16. Kramer CM, Barkhausen J, Bucciarelli-Ducci C, et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. J Cardiovasc Magn Reson. 2020;22(1):17. doi: 10.1186/s12968-020-00615-5.
    Open DOISearch in Google ScholarBack to article
  17. Hundley WE, Bluemke DA, Bogaert J, et al. Society for Cardiovascular Magnetic Resonance (SCMR) guidelines for reporting cardiovascular magnetic resonance examinations. J Cardiovasc Magn Reson. 2022;24(1):29. doi: 10.1186/s12968-021-00827-z.
    Open DOISearch in Google ScholarBack to article
  18. Popa O, Amzulescu M, Bugeac C, et al. Cardiovascular magnetic resonance imaging in myocardial disease. Cureus. 2024;16(4). doi: 10.7759/cureus.58688.
    Open DOISearch in Google ScholarBack to article
  19. Roifman I, Hammer M, Sparkes J, et al. Utilization and impact of cardiovascular magnetic resonance on patient management in heart failure: Insights from the SCMR registry. J Cardiovasc Magn Reson. 2022;24(1):65. doi: 10.1186/s12968-022-00890-0.
    Open DOISearch in Google ScholarBack to article
  20. Bruder O, Wagner A, Lombardi M, et al. European Cardiovascular Magnetic Resonance (EuroCMR) registry — Multinational results from 57 centers in 15 countries. J Cardiovasc Magn Reson. 2013;15:9. doi: 10.1186/1532-429X-15-9.
    Open DOISearch in Google ScholarBack to article
  21. Abbasi SA, Ertel A, Shah RV, et al. Impact of cardiovascular magnetic resonance on management and clinical decision-making in heart failure patients. J Cardiovasc Magn Reson. 2013;15:89. doi: 10.1186/1532-429X-15-89.
    Open DOISearch in Google ScholarBack to article
  22. Kanagala P, Cheng ASH, Singh A, et al. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction: Implications for clinical trials. J Cardiovasc Magn Reson. 2018;20(1):4. doi: 10.1186/s12968-017-0424-9.
    Open DOISearch in Google ScholarBack to article
  23. Won E, Donnino R, Srichai MB, et al. Diagnostic accuracy of cardiac magnetic resonance imaging in the evaluation of newly diagnosed heart failure with reduced left ventricular ejection fraction. Am J Cardiol. 2015;116(7):1082–1087. doi: 10.1016/j.amjcard.2015.06.032.
    Open DOISearch in Google ScholarBack to article
  24. Scatteia A, Dellegrottaglie S. Cardiac magnetic resonance in ischemic cardiomyopathy: Present role and future directions. Eur Heart J Suppl. 2023;25(Suppl C). doi: 10.1093/eurheartjsupp/suad007.
    Open DOISearch in Google ScholarBack to article
  25. Rabbat MG, Kwong RY, Heitner JF, et al. The future of cardiac magnetic resonance clinical trials. JACC Cardiovasc Imaging. 2022;15(12):1967–1970. doi: 10.1016/j.jcmg.2021.07.029.
    Open DOISearch in Google ScholarBack to article
  26. Caforio ALP, Adler Y, Agostini C, et al. Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease. Eur Heart J. 2017;38(35):2649–2662. doi: 10.1093/eurheartj/ehx321.
    Open DOISearch in Google ScholarBack to article
  27. Sado DM, Maestrini V, Piechnik SK, et al. Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload: Myocardial T1 in iron overload. J Magn Reson Imaging. 2015;41(6):1505–1511. doi: 10.1002/jmri.24727.
    Open DOISearch in Google ScholarBack to article
  28. Bruder O, Schneider S, Nothnagel D, et al. EuroCMR (European Cardiovascular Magnetic Resonance) registry: Results of the German pilot phase. J Am Coll Cardiol. 2009;54(15):1457–1466. doi: 10.1016/j.jacc.2009.07.003.
    Open DOISearch in Google ScholarBack to article
  29. Witek NO, Marczak M, Mazurkiewicz L, et al. Role of cardiac magnetic resonance in heart failure of initially unknown etiology: A 10-year observational study. Kardiol Pol. 2022;80(3):278–285. doi: 10.33963/KP.a2021.0186.
    Open DOISearch in Google ScholarBack to article
  30. Onciul S, Popa O-A, Nicolaescu R, et al. Stress perfusion CMR – A report of an initial Romanian experience. Rom J Cardiol. 2021;31(1):52–58. doi: 10.47803/rjc.2021.31.1.52.
    Open DOISearch in Google ScholarBack to article
DOI: https://doi.org/10.2478/rjc-2024-0021 | Journal eISSN: 2734-6382 | Journal ISSN: 1220-658X
Journal RSS Feed
Language: English
Page range: 169 - 178
Published on: Sep 5, 2024
Published by: Romanian Society of Cardiology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
cardiac magnetic resonance,
cardiomyopathies,
late Gadolinium enhancement,
significant clinical impact
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Cardiology,
Surgery,
Cardiac surgery,
Pediatrics and juvenile medicine,
Paediatric cardiology

© 2024 Oana-Andreea Popa, Sebastian Onciul, Thedor Badea, Denisa Marian, Bogdan Rac-Albu, Mihaela Amzulescu, Claudia Bugeac, Oana Chiriac, Luminița Tomescu, Valeriu Gheorghita, Andrei Roșu, published by Romanian Society of Cardiology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 34 (2024): Issue 4 (December 2024)Next article